Meningioma and vision problems

A meningioma is a tumor that originates from the meninges, the protective membranes surrounding the brain and spinal cord. It is the most common type of primary intracranial tumor, and most meningiomas are benign and grow very slowly, often over many years. They are more prevalent in women and in individuals who received radiation to the head during childhood, for conditions such as ringworm. While most meningiomas are not cancerous, their location can significantly impact vital functions.

The effect of a meningioma on vision depends on its precise location. Tumors situated near the optic nerves, within the eye sockets (orbits), or in brain regions responsible for visual processing, can lead to visual symptoms. The pressure exerted by the tumor on these structures can disrupt the transmission of visual information from the eye to the brain or interfere with its processing within the brain itself.

Visual symptoms of a meningioma may include a decrease in visual acuity, visual field defects (loss of part of the visual field), or double vision (diplopia). In addition to visual symptoms, a meningioma can cause more general neurological symptoms, depending on its location and the adjacent structures it compresses. These can include headaches, weakness on one side of the body, personality changes, or seizures.

Suspicion of a meningioma often arises due to the appearance of symptoms or findings on imaging tests performed for other reasons. Diagnosis involves a comprehensive neuro ophthalmic examination, which includes assessing visual acuity, visual fields, eye movements, and examining the back of the eye (fundus). These tests help identify the extent of visual impairment and the structures involved.

MRI is the main imaging test when a meningioma is suspected. Depending on the location and visual symptoms, dedicated images of the brain, optic nerves and orbits may be needed. Imaging shows the size, position and effects on nearby structures.

A characteristic MRI appearance can support a presumed diagnosis, and some patients can be monitored without taking a tissue sample. However, imaging alone cannot definitively establish the tumor's tissue type or grade. When tissue is obtained during surgery, laboratory examination provides the definitive pathological diagnosis. The team weighs the value of tissue confirmation against the risks of an operation.

Treatment options for meningioma depend on many factors, including tumor size, location, growth rate, symptom severity, and impact on quality of life. When a meningioma is small and asymptomatic, periodic monitoring with repeat eye examinations and imaging may be sufficient to track its size and ensure it is not growing or affecting vital functions.

A growing or symptomatic meningioma may need active treatment. Surgery is often considered for an accessible intracranial tumor when the expected benefit outweighs the risks. Radiation may be used when complete removal is unsafe or as additional treatment after surgery.

A meningioma arising from the sheath immediately around the optic nerve requires a different approach. Removing it can seriously damage the nerve and its blood supply. For a tumor causing progressive visual decline, fractionated radiation is often favored to control growth while preserving vision; selected stable cases can be observed. Surgery has a limited role in particular circumstances. Treatment is planned by a multidisciplinary team, including neurosurgery, radiation oncology and neuro ophthalmology.

After diagnosis and initiation of treatment, regular follow up is necessary to assess treatment effectiveness and identify any changes in the condition. You should contact your treating physician for any worsening of visual symptoms, such as a sudden decrease in vision, new onset of double vision, or significant changes in your visual field. Additionally, report any new or worsening neurological symptoms, such as severe headaches, weakness, or behavioral changes.